Involvement of PARK2-Mediated Mitophagy in Idiopathic Pulmonary Fibrosis Pathogenesis
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Fibroblastic foci, known to be the leading edge of fibrosis development in idiopathic pulmonary fibrosis (IPF), are composed of fibrogenic myofibroblasts. Autophagy has been implicated in the regulation of myofibroblast differentiation. Insufficient mitophagy, the mitochondria-selective autophagy, results in increased reactive oxygen species, which may modulate cell signaling pathways for myofibroblast differentiation. Therefore, we sought to investigate the regulatory role of mitophagy in myofibroblast differentiation as a part of IPF pathogenesis. Lung fibroblasts were used in in vitro experiments. Immunohistochemical evaluation in IPF lung tissues was performed. PARK2 was examined as a target molecule for mitophagy regulation, and a PARK2 knockout mouse was employed in a bleomycin-induced lung fibrosis model. We demonstrated that PARK2 knockdown-mediated mitophagy inhibition was involved in the mechanism for activation of the platelet-derived growth factor receptor (PDGFR)/PI3K/AKT signaling pathway accompanied by enhanced myofibroblast differentiation and proliferation, which were clearly inhibited by treatment with both antioxidants and AG1296, a PDGFR inhibitor. Mitophagy inhibition–mediated activation of PDGFR signaling was responsible for further autophagy suppression, suggesting the existence of a self-amplifying loop of mitophagy inhibition and PDGFR activation. IPF lung demonstrated reduced PARK2 with concomitantly increased PDGFR phosphorylation. Furthermore, bleomycin-induced lung fibrosis was enhanced in PARK2 knockout mice and subsequently inhibited by AG1296. These findings suggest that insufficient mitophagy-mediated PDGFR/PI3K/AKT activation, which is mainly attributed to reduced PARK2 expression, is a potent underlying mechanism for myofibroblast differentiation and proliferation in fibroblastic foci formation during IPF pathogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“| Pulmonary fibrosis | Whole‐body deletion of Prkn | Accelerated development of bleomycin‐induced lung fibrosis after mitophagy inhibition | Kobayashi et al (2016) |”
From Autophagy in major human diseases (2021) · cites this paper as Kobayashi et al (2016)
In the citing paper
“In accordance with this notion, genetic loss of Pink1 and Prkn accelerates the development of the fibrotic phenotype in bleomycin‐treated mice, linked to alveolar epithelial cell II (AECII) loss and accrued inflammation (Bueno et al, 2015; Kobayashi et al, 2016).”
From Autophagy in major human diseases (2021) · cites this paper as Kobayashi et al, 2016
Citations
Cites
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.
Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., & Yoshimori, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5720 · Cited by 6,605 · cited 1×
“Yoshimori (Osaka University, Osaka, Japan) and was cloned into the pEGFP-C1 vector (21).”
MethodEfficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
Autophagy and the Integrated Stress Response
Kroemer, G., Mariño, G., & Levine, B. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.023 · Cited by 3,506
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1
Geisler, S., Holmström, K. M., Skujat, D., Fiesel, F. C., Rothfuss, O. C., Kahle, P. J., & Springer, W. (2010) · Nature Cell Biology · doi:10.1038/ncb2012 · Cited by 2,835 · cited 2×
“Both PINK1 and PARK2 are essential for mitophagy and mitochondrial ROS regulation (25).”
BackgroundKing, T. E., Pardo, A., & Selman, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60052-4 · Cited by 2,194
Rubinsztein, D. C., Mariño, G., & Kroemer, G. (2011) · Cell · doi:10.1016/j.cell.2011.07.030 · Cited by 2,107
Dynamics and diversity in autophagy mechanisms: lessons from yeast
Nakatogawa, H., Suzuki, K., Kamada, Y., & Ohsumi, Y. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2708 · Cited by 1,725
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705 · cited 1×
“It has been reported that mitophagy inhibition by genetic deletion of PINK1 can be rescued by transgenic PARK2 expression, but not vice versa, indicating the pivotal role of PARK2 in mitophagy regulation (36).”
BackgroundPINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis
Bueno, M., Lai, Y.-C., Romero, Y., Brands, J., St. Croix, C. M., Kamga, C., Corey, C., Herazo-Maya, J. D., Sembrat, J., Lee, J. S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci74942 · Cited by 627 · cited 4×
“with enhanced apoptosis in alveolar epithelial cells, which was involved in lung fibrosis development in BLM-treated PINK1 KO mice (18).”
BackgroundResultInfluential
Cited by
Items 101–144 of 144
Cloonan, S. M. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201708-1593ed · Cited by 9
“Are defects in the somatic sequence of mtDNA, an observation noted by Gazdhar and colleagues (8) in a scleroderma model of lung fibrosis, responsible for this altered metabolism and, in turn, release of mtDNA? Other questions include: how does mtDNA escape from the cell in this apparently active process? Is mtDNA bein…”
BackgroundWang, L.-J., Guo, P., Zhang, S., Wang, S., Chen, Y., Yan, H., & Zhang, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1668281 · Cited by 14
Targeting mitochondrial dysfunction: an innovative strategy for treating renal fibrosis
Wu, Y.-J., Yang, Y., Yan, Y.-L., Yang, H.-Y., & Du, J. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05297-w · Cited by 11
“Furthermore, new evidence from other organs suggests that altered mitochondrial quality control capacity in different cell types may have different or even opposite effects on tissue damage and repair [148, 149].”
Wang, L., Wan, R., Chen, X., Guo, X., Li, Z., Zhao, W., Yan, P., & Yu, G. (2022) · Canadian Respiratory Journal · doi:10.1155/2022/9663354 · Cited by 8
Abdelrahman, R. S., & Shawky, N. M. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23071 · Cited by 8
Alamandine reduces oxidative stress and preserves the epithelium in BLM-induced pulmonary fibrosis
Blanco, A., Fernandes, R., Guimarães, G. R., & Rigatto, K. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177995 · Cited by 6
Yang, Y., Huang, G., Zhang, T., Ling, Y., Jiang, J., Du, D., Ma, Y., & Tao, S. (2025) · Advanced Science · doi:10.1002/advs.202501718 · Cited by 8
Karampitsakos, Τ., Galaris, A., Barbayianni, I., DeIuliis, G., Ahangari, F., Sampsonas, F., Sotiropoulou, V., Aidinis, V., Bennett, A. M., Herazo‐Maya, J. D., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13061166 · Cited by 6
“PINK1 deficiencyinduced mitochondrial function derangements have been associated with enhanced AECIIs apoptosis [14] and reduced fibroblasts-to-myofibroblasts differentiation [32].”
BackgroundFarkas, L., Horowitz, J. C., & Mora, A. L. (2022) · European Respiratory Journal · doi:10.1183/13993003.01702-2022 · Cited by 5
Tao, H., Lv, Q., Zhang, J., Chen, L., Yang, Y., & Sun, W. (2024) · Stem Cells International · doi:10.1155/2024/3429565 · Cited by 5
Imaduddin, U., Berbudi, A., & Rohmawaty, E. (2024) · Journal of Experimental Pharmacology · doi:10.2147/jep.s439932 · Cited by 6
“19 Inflammation is one of a key factor in pulmonary fibrosis, causing severe damage to alveolar epithelium and disrupting alveolar structure.”
BackgroundLiu, Q., Meng, F.-L., Du, J., Li, W., Zhou, S., & Li, Y. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112170 · Cited by 6
Chang, M., Zhou, Q., Guan, Y., Zhao, Y., Guo, S., Qu, Q., Liu, L., Li, Z., Zhao, X., Cao, H., et al. (2026) · Antioxidants and Redox Signaling · doi:10.1177/15230864251411565 · Cited by 3
“Furthermore, PINK1 de fi ciency is associated with upregulation of TGF-b 1 expression, promoting extracellular matrix deposition, implicating mitochondria in the fi brogenesis process of pulmonary fi brosis (Bueno et al., 2015; Kobayashi et al., 2016).”
Guan, X., Zhong, W., Tang, W., Yu-biao, L., Chen, M.-R., Li, J.-L., Zhang, C.-Y., Zhou, Y., Guan, C., Wu, J.-N., et al. (2026) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-026-06161-w · Cited by 4
“Previous reports have high - lighted the potential involvement of insufficient mitophagy in fibroblast senescence [ 16 , 17].”
Epithelial Ablation of Miro1/Rhot1 GTPase Augments Lung Inflammation by Cigarette Smoke
Sharma, S., Wang, Q., Muthumalage, T., & Rahman, I. (2021) · Pathophysiology · doi:10.3390/pathophysiology28040033 · Cited by 3
Zifa, E., Sinis, S. I., Psarra, A. G., Mouikis, A., Pozantzi, A., Rossi, K., Malli, F., Dimeas, I. E., Kirgou, P., Gourgoulianis, K. I., et al. (2025) · Biochemical Genetics · doi:10.1007/s10528-025-11071-w · Cited by 2
“Deficient mitophagy in IPF results in dysfunctional mitochondrial accumulation, increased ROS production, and pro-fibrotic pathway activation (Kobayashi et al. 2016 Jul 15).”
Li, J., Chen, X., Ou, L., Ren, L., Xia, J., & Cheng, B. (2025) · Materials & Design · doi:10.1016/j.matdes.2025.114626 · Cited by 2
Wang, A., Ma, T., Yu, J., Hu, Y., & Di, X. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116622 · Cited by 4
Mitophagy promotes lung repair and regeneration by restoring epithelial metabolic fitness
Wu, P., Chen, J., Liu, L., Wang, P., Lu, T., Shen, S., Cao, Y., Sui, Y., Liu, R., Huan, X., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71728-x · Cited by 2
“Mitochondrialdysfunction has been observed in various pulmonary diseases, including chronic conditions such as IPF and chronic obstructive pulmonary disease (COPD), as well as in infection-induced acute lung injury 16,17,26,28,82 – 85 .”
Amin, R., Pandey, R., Vaishali, K., Acharya, V. K., Sinha, M. K., & Kumar, N. (2023) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557523666230816090112 · Cited by 4
Bai, Y., Yin, X., Zhang, Q., Sang, X., Wu, W., Shao, D., Zhao, P., & Li, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-95175-8 · Cited by 2
“…mediated by Park2 leads to excessive ROS production, which activates the platelet-derived growth factor receptor (PDGFR)/mammalian target of rapamycin (mTOR) signaling pathway, resulting in the differentiation and proliferation of myofibroblasts and ultimately contributing to fibrosis 11 .”
Kumari, S., Singh, P., Dash, D., & Singh, R. (2024) · Research Square · doi:10.21203/rs.3.rs-4004020/v1 · Cited by 2
Respiratory Pathophysiology Through the Lens of Mitochondria
Noguchi, M., Iwata, K., & Shintani, N. (2025) · Clinical bioenergetics · doi:10.3390/clinbioenerg1010004 · Cited by 2
“These findings indicate that reduced PARKIN-mediated mitophagy underlies IPF pathogenesis by driving the PDGFR/PI3K/AKT axis [85].”
Chen, X., Wang, D., Zhou, Y., Li, L., Zhu, T., Zhao, R., Lu, M., & Mu, B. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10665-2 · Cited by 3
“Parkin deficiency induces mitophagy failure, mitochondrial ROS production, and activation of the PDGFR/mTOR path - way, promoting myofibroblast differentiation [94 ].”
Selective Autophagy: A Potential Player in Cutaneous Wound Healing
Jin, W., Ren, D., Yu, M., Li, Y., Zhang, W., & Guo, S. (2025) · Advances in Wound Care · doi:10.1177/21621918251372954 · Cited by 1
“168 However, pirfenidone blocks PARK2 knockdown-induced myo fi broblast differentiation by lowering mtROS levels and PDGFR-PI3K-AKT activation.”
Advances in understanding mitophagy's role in lung injury
Du, W., Yang, Y., Zhang, T., Jiang, J., Du, D., Huang, G., & Tao, S. (2026) · Chinese Journal of Traumatology · doi:10.1016/j.cjtee.2025.06.004 · Cited by 1
“42,43 For alveolar macrophages, upregulation of mitophagy during pulmonary fibrosis can reduce apoptosis.”
Zhang, L., Zhang, Y., 韩流, Wang, J., Hou, L., & Fu, S. (2026) · Molecular Medicine · doi:10.1186/s10020-026-01521-5 · Cited by 1
Sharma, S., Wang, Q., Muthumalage, T., & Rahman, I. (2021) · Preprints.org · doi:10.20944/preprints202108.0220.v1 · Cited by 1
“…proteins indicate that our results are in consistent with previous studies that have shown reduced proteins along with the increase in the levels of ROS in the damaged mitochondria in the lung epithelial cells when exposed to CS (Ito et al., 2015; Kobayashi et al., 2016; Sundar et al., 2019).”
ResultComorbid Metabolic Disorders in Chronic Lung Diseases
Gumeniuk, М. (2019) · Infusion & Chemotherapy · doi:10.32902/2663-0338-2019-3-5-15 · Cited by 1
Targeting the Ubiquitin Proteasome System in Pulmonary Fibrosis
Thorley, A. J., Krautwald, S., & Rowlands, D. J. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781788015783-00165
TGF-β-Induced CCR8 Promoted Macrophage Transdifferentiation into Myofibroblast-Like CellsPreprint
Liu, H., Guan, Q., Zhao, P., & Li, J. (2021) · Research Square · doi:10.21203/rs.3.rs-757594/v1
Reboiras, R. F. (1998) · Cinemanía
Sandbo, N. K. (2018) · Respiratory medicine · doi:10.1007/978-3-319-99975-3_7
Sharma, S., Wang, Q., Muthumalage, T., & Rahman, I. (2021) · Preprints.org · doi:10.20944/preprints202108.0220.v2
Aidinis, V., & Magkrioti, C. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733575125.793555109
Ding, G., Duan, Q., Wang, W. C., Yuan, J., Xu, W., & Lu, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-3460274/v1
Kumari, S., Singh, P., & Singh, R. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4761569
Wang, Z., Yang, M., Li, S., Chi, H., Wang, J., & Xiao, C. (2024) · PubMed Central · doi:10.12122/j.issn.1673-4254.2024.04.07 · Cited by 1
Wang, W., Zhang, Y., Huang, W., Yuan, Y., Hong, Q., Xie, Z., Li, L., Chen, Y., Li, X., & Meng, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26561180
Idiopathic Pulmonary Fibrosis: Analysis of Predisposing Variants in Patients with Familial Forms
Stanghellini, I., Bonora, E., Sebastiani, M., Salvarani, C., Gozzi, F., Andrisani, D., Tonelli, R., Rizzardi, N., Bergamini, C., Isidori, F., et al. (2026) · Biomedicines · doi:10.3390/biomedicines14010138
“In greater detail, alterations of PRKN have been reported as a cause of increased oxidative stress, altered mitophagy, and accumulation of dysmorphic mitochondria [19].”
Mitochondrial dysfunction in pulmonary fibrosis: from mechanisms to therapeutic opportunities
Jin, X., Sang, L., Zhu, J., Zhong, Z., & Sun, J. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118164
Yoshida, M., & Araya, J. (2026) · European Respiratory Review · doi:10.1183/16000617.0278-2025
“…previously demonstrated that PARK2 knockout mice exhibit enhanced bleomycin-induced lung fibrosis with elevated myofibroblast activation, and IPF patient lungs demonstrate reduced PARK2 expression accompanied by aberrant platelet-derived growth factor receptor signalling in fibroblastic foci [15].”
Self-citationEtrouth, S., Zhu, Y., & Zhang, D. (2026) · Journal of Respiration · doi:10.3390/jor6030021
“In senescent cells, mitophagy is downregulated, leading to decreased PTEN-induced putative kinase 1 [200].”
Mitophagy in idiopathic pulmonary fibrosis: from molecular mechanisms to therapeutic opportunities
He, M., Li, Y., Huang, H., Cong, Z., & Yang, Y. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1925197
“PINK1/Parkin-mediated mitophagy eliminates mitochondrial ROS production and inhibits fibroblast differentiation (Kobayashi et al., 2016; Álvarez et al., 2017; Malsin et al., 2018; Lei and Kazlauskas, 2014).”
Metadata
- Authors
- Kobayashi, K., Araya, J., Minagawa, S., Hara, H., Saito, N., Kadota, T., Sato, N., Yoshida, M., Tsubouchi, K., Kurita, Y., Ito, S., Fujita, Y., Takasaka, N., Utsumi, H., Yanagisawa, H., Hashimoto, M., Wakui, H., Kojima, J., Shimizu, K., Numata, T., Kawaishi, M., Kaneko, Y., Asano, H., Yamashita, M., Odaka, M., Morikawa, T., Nakayama, K., & Kuwano, K.
- Affiliations
- Jikei University School of Medicine (JP)
- Corresponding author
- Araya, Jun
- ORCID
- Kobayashi, Kenji
- Araya, Jun
- Minagawa, Shunsuke
- Hara, Hiromichi
- Saito, Nayuta
- Kadota, Tsukasa
- Sato, Nahoko
- Yoshida, Masahiro
- Tsubouchi, Kazuya
- Ito, Saburo
- Fujita, Yu
- Takasaka, Naoki
- Utsumi, Hirofumi
- Yanagisawa, Haruhiko
- Hashimoto, Mitsuo
- Numata, Takanori
- Asano, Hisatoshi
- Yamashita, Makoto
- Odaka, Makoto
- Nakayama, Katsutoshi
- Kuwano, Kazuyoshi
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-07
- Volume
- 197
- Issue
- 2
- Pages
- 504-516
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2414956908
- Cited by
- 145
- References
- 37
- Citations by year
- 2026: 11 · 2025: 15 · 2024: 14 · 2023: 16 · 2022: 12 · 2021: 18 · 2020: 20 · 2019: 13 · 2018: 13 · 2017: 10 · 2016: 2
- FWCI
- 11.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Washington
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic pulmonary fibrosis, mitophagy, PARK2, myofibroblast differentiation, fibroblastic foci, autophagy, reactive oxygen species, bleomycin-induced lung fibrosis, AG1296, antioxidants, lung fibroblasts
- MeSH terms
- Animals, Cell Differentiation, Fluorescent Antibody Technique, Humans, Immunohistochemistry, Blotting, Western, Signal Transduction, Receptors, Platelet-Derived Growth Factor, Mice, Knockout, Phosphatidylinositol 3-Kinases, In Situ Nick-End Labeling, Ubiquitin-Protein Ligases, Microscopy, Electron, Transmission, Proto-Oncogene Proteins c-akt, Mice, Idiopathic Pulmonary Fibrosis, Myofibroblasts, Mitophagy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.